Project: A novel platform enabling prediction of disease progression in heart failure patients.
| Acronym | HeartAssess (Reference Number: 114585) |
| Duration | 01/04/2021 - 01/04/2024 |
| Project Topic | HeartAssess will deliver a prognostic tool to predict disease progression in heart failure (HF) patients. The platform assesses cardiometabolic parameters by integrating data from two sensors and visualizing analyzed results on a user-friendly dashboard. An AI algorithm will be trained to predict disease progression. By the end of the project, the platform’s predictive value will have been validated in a feasibility pilot study and will be ready for a pivotal trial required to enter the clinic. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 14 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Manatec SARL, d.b.a. Manatec Biomedical | Partner | France |
| 2 | Radboud University Medical Center | Partner | Netherlands |
| 3 | Splendo Consulting B.V. | Coordinator | Netherlands |
| 4 | VO2 Master Health Sensors Inc. | Partner | Canada |